Boston Scientific…
USUSDBoston Scientific Corp (LSE:0HOY) — Medical Devices. Número de bolsas en las que cotizan las acciones de la empresa: 5. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.
Sobre la Empresa
- Sitio Web
- bostonscientific.com
- Relaciones con los Inversores
- bostonscientific.com/en-US/investor-relations-redirect.html
- Sector
- Healthcare · Medical Devices
- Sede Central
- MARLBOROUGH, United States
- Gestión
- Últimos Informes
- Empleados
- 59 000
- Fundada
- 1979
- IPO
- 1992-05-19
- Acciones en Circulación
- 1.45 mil M a 2026-07-30
- Capital Flotante
- 1.44 mil M
- Capitalización Bursátil
- 66.06 mil M USD
- Insiders
- 0.25%
- Inversores Institucionales
- 94.73%
- Industria (SIC)
- Surgical & Medical Instruments & Apparatus
- Forma Jurídica
- XTIQ
- ISIN
- US1011371077
- LEI
- Y6ZDD9FP4P8JSSJMW954
- P/B
- 2.48
- FCF
- 3.63 mil M USD
- Deuda
- 10.9 mil M USD2.9 a. de FCF
- Resultados y FCF — para los 12 meses hasta 30.06.2026 (el último informe de la empresa).
- Beneficio Neto
- NAV
Descripción
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Bolsas y Tickers
| Bolsa | Ticker | Moneda | Precio | Tipo |
|---|---|---|---|---|
| acciones ordinarias | ||||
| US USA Stocks | BSX principal | USD | 42.69 +0.61% | acciones ordinarias |
| LSE London Stock Exchange | 0HOY IOB | GBP | — | acciones ordinarias |
| MI Borsa Italiana (Milan) | 1BSX secundaria | EUR | 38.565 +2.88% | acciones ordinarias |
| VI Vienna Stock Exchange | BSXC secundaria | EUR | 39.785 +1.20% | acciones ordinarias |
| XETRA Xetra | BSX secundaria | EUR | 39.825 +1.32% | acciones ordinarias |
| certificado de depósito | ||||
| SA B3 Sao Paulo | B1SX34 | BRL | 53.28 -3.58% | certificado de depósito |
Noticias de Esta Semana
Comunicados de prensa desde la página web para inversores de la empresa, actualizados diariamente. Los enlaces conducen a la página web de la empresa. Los titulares están en el idioma original, como en la página web de la empresa.
| 28.10.2026 | Learn about our Q3 2026 earnings |
Principales Accionistas
| Titular | Participación | Acciones | Fecha del Informe |
|---|---|---|---|
| Blackrock Inc. | 8.95% | 129.68 M | 2026-06-30 |
| Vanguard Capital Managem… | 6.7% | 97.09 M | 2026-06-30 |
| State Street Corporation | 4.84% | 70.11 M | 2026-06-30 |
| Primecap Management Comp… | 3.49% | 50.52 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.26% | 47.18 M | 2026-06-30 |
| FMR, LLC | 3.15% | 45.7 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.66% | 38.52 M | 2026-06-30 |
| Geode Capital Management… | 2.31% | 33.44 M | 2026-06-30 |
| VANGUARD CHESTER FUNDS-V… | 2.13% | 30.83 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.06% | 29.79 M | 2026-06-30 |
| Shaw D.E. & Co., Inc. | 1.76% | 25.46 M | 2026-06-30 |
| Massachusetts Financial… | 1.72% | 24.86 M | 2026-06-30 |
| JPMORGAN CHASE & CO | 1.65% | 23.91 M | 2026-06-30 |
| iShares Trust-iShares Co… | 1.38% | 20.05 M | 2026-07-31 |
| Fidelity Concord Street… | 1.33% | 19.22 M | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.26% | 18.21 M | 2026-08-31 |
| VANGUARD SPECIALIZED FUN… | 1.04% | 15.07 M | 2026-04-30 |
| Growth Fund of America | 0.78% | 11.25 M | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.74% | 10.68 M | 2026-08-31 |
| Fidelity Rutland Square… | 0.66% | 9.61 M | 2026-07-31 |
| MAHONEY MICHAEL F (Chief… | ≈0.11% | 1.61 M | 2026-08-03 |
| BRENNAN DANIEL J (Chief… | ≈0.02% | 225 808 | 2025-02-19 |
| FITZGERALD JOSEPH MICHAE… | ≈0.02% | 219 141 | 2026-02-13 |
| BUTCHER ARTHUR C (Office… | ≈0.01% | 77 115 | 2026-05-01 |
| SUNUNU JOHN E (Director) | ≈0% | 54 723 | 2025-05-08 |
| BROWN VANCE R (General C… | ≈0% | 54 244 | 2026-02-13 |
| WICHMANN DAVID S (Direct… | ≈0% | 45 382 | 2026-05-07 |
| MONSON JONATHAN R (Chief… | ≈0% | 39 063 | 2026-07-01 |
| LUDWIG EDWARD J. (Direct… | ≈0% | 30 359 | 2026-07-31 |
| CARRUTHERS WENDY (Office… | ≈0% | 29 308 | 2024-12-02 |
Inicia Sesión con Google